DVN
18
-3
PAYX
50
3
UNP
43
3
PPG
64
-4
SYK
59
2
LRCX
59
-5
NUE
47
-4
GOOGL
67
8
AMT
37
-8
DE
56
-2
UNM
70
-2
APH
61
-6
GME
57
-3
KHC
18
-2
GOOG
81
10
CSX
53
3
AXP
70
6
URBN
72
2
VNO
56
-3
HON
65
3
DVN
18
-3
PAYX
50
3
UNP
43
3
PPG
64
-4
SYK
59
2
LRCX
59
-5
NUE
47
-4
GOOGL
67
8
AMT
37
-8
DE
56
-2
UNM
70
-2
APH
61
-6
GME
57
-3
KHC
18
-2
GOOG
81
10
CSX
53
3
AXP
70
6
URBN
72
2
VNO
56
-3
HON
65
3
Financhill
Back

Y-mAbs Therapeutics Stock Predictions

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
29

YMAB
Y-mAbs Therapeutics

Last Price:
10.01
Seasonality Move:
12.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Y-mAbs Therapeutics Stock Forecast

  • Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 13.6% based on the past 6 years of stock performance.
  • Y-mAbs Therapeutics has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Y-mAbs Therapeutics Stock Undervalued?
    The current Y-mAbs Therapeutics [YMAB] share price is $10.01. The Score for YMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • YMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Y-mAbs Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 13.6% based on the past 6 years of stock performance.

Y-mAbs Therapeutics Stock Rating

Sell
29
Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics overpriced?

  • Y-mAbs Therapeutics has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Y-mAbs Therapeutics Stock Price History

Is YMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ymabs.com

52-Week Data

52-Week High:
20.90
52-Week Low:
6.09

Prediction Charts

Market Cap:
448.34M
Price in USD:
10.01
Volume:
167.63K
Beta:
0.72

Technical Analysis

SMA50:
13.07
SMA100:
12.98
SMA200:
13.45
52-Wk Change:
50.3%

Stock Predictions

  • Is Y-mAbs Therapeutics stock public?
    Yes, Y-mAbs Therapeutics is a publicly traded company.
  • What is the Y-mAbs Therapeutics stock quote today?
    The Y-mAbs Therapeutics stock price is 10.01 USD today.
  • How to buy Y-mAbs Therapeutics stock online?
    You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-21 10.56 10.10 10.92 9.85
Nov-22 10.09 10.41 10.49 9.93
Nov-25 10.64 10.56 11.24 10.55
Nov-26 10.54 10.77 11.04 10.38
Nov-27 10.86 11.88 12.00 10.67
Nov-29 11.88 11.92 12.40 11.75
Dec-2 12.16 11.79 12.16 11.29
Dec-3 11.52 10.57 11.86 10.55
Dec-4 10.52 10.38 10.59 10.18
Dec-5 10.72 10.30 11.45 10.24
Dec-6 10.33 10.54 10.87 10.25
Dec-9 10.61 10.26 10.81 10.19
Dec-10 10.21 10.28 10.66 10.21
Dec-11 10.27 10.01 10.34 9.88

Y-mAbs Therapeutics Earnings

Y-mAbs Therapeutics Earnings Report: Per Share Y-mAbs Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Y-mAbs Therapeutics Forecast Revenue Growth

Y-mAbs Therapeutics Stock Analysis: Historical quarterly revenues per share for Y-mAbs Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.

* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.